BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2023 5:08:46 AM | Browse: 619 | Download: 1624
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 87194
Country United Kingdom
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Manuscript Source Unsolicited Manuscript
All Author List Sophie Jose, Amy Zalin-Miller, Craig Knott, Lizz Paley, Daniela Tataru, Helen Morement, Mireille B Toledano and Shahid A Khan
ORCID
Author(s) ORCID Number
Sophie Jose http://orcid.org/0000-0002-3536-4344
Amy Zalin-Miller http://orcid.org/0000-0002-3123-3566
Craig Knott http://orcid.org/0000-0002-8593-6216
Lizz Paley http://orcid.org/0000-0002-3879-5377
Daniela Tataru http://orcid.org/0009-0002-2655-4717
Helen Morement http://orcid.org/0000-0001-6141-2816
Mireille B Toledano http://orcid.org/0000-0001-5695-6210
Shahid A Khan http://orcid.org/0000-0003-2538-0911
Funding Agency and Grant Number
Funding Agency Grant Number
AMMF, National Disease Registration Service, National Health Service England
Corresponding Author Sophie Jose, PhD, Senior Statistician, Health Data Analysis, Health Data Insight CIC, CPC4 Capital Park, Cambridge CB21 5XE, United Kingdom. sophie.jose@nhs.net
Key Words Cholangiocarcinoma; Biliary tract cancer; Liver cancer; Treatment; Surgery; Systemic therapy; Chemotherapy; Stent; England
Core Tip Outcomes for cholangiocarcinoma (CCA) are extremely poor, with late presentation meaning curative surgery is not an option for many. Systemic therapies to prolong life are limited and stent insertion for disease management is complex. In a national cohort, treatments received (surgery, systemic therapy, stent insertion) by CCA patients across geographic areas were investigated. Half of patients did not receive any of the treatments considered. The proportion that received treatments significantly varied across England. These data provide novel evidence of low and varied treatment rates for CCA patients, warranting further investigation by healthcare providers to try to improve outcomes and reduce inequality.
Publish Date 2023-12-14 05:08
Citation Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA. Cohort study to assess geographical variation in cholangiocarcinoma treatment in England. World J Gastrointest Oncol 2023; 15(12): 2077-2092
URL https://www.wjgnet.com/1948-5204/full/v15/i12/2077.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i12.2077
Full Article (PDF) WJGO-15-2077-with-cover.pdf
Full Article (Word) WJGO-15-2077.docx